Clinical Trial Update: PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm [NA]

View source ↗

Summary

A completed multi-center trial evaluating a novel implanted continuous glucose monitoring (CGM) system with a next-generation transmitter and algorithm; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Senseonics CGM system (implanted CGM with next-generation transmitter and algorithm)

Snippet

Sponsor: Senseonics, Inc. | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2024-02-12